A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year. Evidence for genetic influence on smoking behaviour and nicotine dependence (ND) has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health. Smoking is the major risk factor for lung cancer (LC) and is one of the main risk factors for peripheral arterial disease (PAD). Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking-related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genome-wide association study that used low-quantity smokers as controls, and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene-environment interaction, highlighting the role of nicotine addiction in the pathology of other serious diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These biobank efforts, pioneered in studies such as the Framingham Cohort70 and the efforts of DeCODE in Iceland71,72, now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond73–76.”
From A brief history of human disease genetics (2020) · cites this paper as [72]
In the citing paper
“This association has been replicated either directly or using highly correlated SNPs by several groups (92–97).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“The replicated nicotine dependence loci tagged by rs16969968 (96,100–102) and rs578776 (101,103) have also been reported to influence lung cancer risk in several genome-wide association studies.”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“This second association with nicotine dependence has been replicated in additional studies using the same SNP or a highly correlated SNP (92,95,96,98).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“some indicate that the association could be explained through an indirect effect on risk for smoking (96)”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Recommended standards for reports dealing with lower extremity ischemia: Revised version
Rutherford, R. B., Baker, J. D., Ernst, C., Johnston, K. W., Porter, J. M., Ahn, S., & Jones, D. N. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70045-4 · Cited by 3,562
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Self-citationGenotype-environment interaction and correlation in the analysis of human behavior.
Plomin, R., DeFries, J. C., & Loehlin, J. C. (1977) · Psychological Bulletin · doi:10.1037/0033-2909.84.2.309 · Cited by 1,685
Dormandy, J., & Rutherford, R. B. (2000) · PubMed · Cited by 1,635
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Cited by
Items 501–600 of 1,001
VanderWeele, T. J., & Vansteelandt, S. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr334 · Cited by 46
Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2
Ware, J. J., Chen, X., Vink, J. M., Loukola, A., Minică, C. C., Pool, R., Milaneschi, Y., Mangino, M., Menni, C., Chen, J., et al. (2016) · Scientific Reports · doi:10.1038/srep20092 · Cited by 51
Schuit, E., Panagiotou, O. A., Munafo, M. R., Bennett, D., Bergen, A. W., & David, S. P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011823.pub2 · Cited by 45
RetractedJin, G., Zhu, M., Yin, R. H., Shen, W., Liu, J., Sun, J., Wang, C., Dai, J., Ma, H., Wu, C. H., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.03.009 · Cited by 46
Scherf, D. B., Sarkisyan, N., Jacobsson, H., Claus, R., Bermejo, J. L., Peil, B., Gu, L., Muley, T., Meister, M. A., Dienemann, H., et al. (2012) · Oncogene · doi:10.1038/onc.2012.344 · Cited by 48
Integrative genomics of chronic obstructive pulmonary disease
Hobbs, B. D., & Hersh, C. P. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.086 · Cited by 47
Pharmacogenetics of Drug Dependence: Role of Gene Variations in Susceptibility and Treatment
Khokhar, J. Y., Ferguson, C. S., Zhu, A. Z. X., & Tyndale, R. F. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105826 · Cited by 48
Johnson, C., Drgon, T., Walther, D., & Uhl, G. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019210 · Cited by 44
“Combined data from linkage and initial GWA studies [6,7,8,9,10,11,12,13,14,15,16,17,18,19] suggest that much of the genetic influence on vulnerability to substance dependence is likely to be polygenic.”
BackgroundGenome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries
Baurley, J. W., Edlund, C. K., Pardamean, C. I., Conti, D. V., Krasnow, R. E., Javitz, H. S., Hops, H., Swan, G. E., Benowitz, N. L., & Bergen, A. W. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw117 · Cited by 46
Chen, L.-S., Baker, T. B., Hung, R. J., Horton, A. C., Culverhouse, R., Hartz, S. M., Saccone, N. L., Cheng, I. C., Deng, B., Han, Y., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.012 · Cited by 49
“, 2015a), and earlier onset and higher probability of lung cancer (Amos et al., 2008; Thorgeirsson et al., 2008; Chen et al., 2015a; Hung et al., 2008a; Lips et al., 2010; Spitz et al., 2008).”
BackgroundInfluentialSelf-citationZhang, H., Guo, L., & Chen, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s248436 · Cited by 45
Foy, J., Bertolus, C., William, W. N., & Saintigny, P. (2013) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2013.04.010 · Cited by 52
Ion Channels in Hematopoietic and Mesenchymal Stem Cells
Pillozzi, S., & Becchetti, A. (2012) · Stem Cells International · doi:10.1155/2012/217910 · Cited by 46
Zintzaras, E., & Zdoukopoulos, N. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp094 · Cited by 44
“Moreover, a polymorphism in the CHRNA3 gene (831C/T) was evaluated in 5 distinct Caucasian populations, with significant results being reported in 2 (47).”
BackgroundBiomarkers and Genetics in Peripheral Artery Disease
Hazarika, S., & Annex, B. H. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.263798 · Cited by 47
Olfson, E., Saccone, N. L., Johnson, E. O., Chen, L.-S., Culverhouse, R., Doheny, K., Foltz, S. M., Fox, L., Gogarten, S. M., Hartz, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.105 · Cited by 43
Ray, R., Mitra, N., Baldwin, D. A., Guo, M., Patterson, F., Heitjan, D. F., Jepson, C., Wileyto, E. P., Wei, J., Payne, T. J., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.7 · Cited by 46
Risk Perceptions and Family History of Lung Cancer: Differences by Smoking Status
Chen, L. S., & Kaphingst, K. A. (2010) · Public Health Genomics · doi:10.1159/000294151 · Cited by 48
Dong, J., Jin, G., Wu, C. H., Guo, H., Zhou, B., Lv, J., Lu, D., Shi, Y., Shu, Y., Xu, L., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003190 · Cited by 47
Walsh, K. M., Gorlov, I. P., Hansen, H. M., Wu, X., Spitz, M. R., Zhang, H., Lu, E. Y., Wenzlaff, A. S., Sison, J. D., Wei, C., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1007-t · Cited by 45
Tyndale, R. F., Zhu, A. Z. X., George, T. P., Cinciripini, P. M., Hawk, L. W., Schnoll, R. A., Swan, G. E., Benowitz, N. L., Heitjan, D. F., & Lerman, C. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128109 · Cited by 45
Pathways to precision medicine in smoking cessation treatments
Chen, L., Horton, A. C., & Bierut, L. J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.033 · Cited by 46
“For example, variants in the genes encoding the α5-α3-β4 nicotinic receptor subunits show promise as a biomarker for predicting risk for developing nicotine dependence [19–22], lung cancer [23, 24], chronic obstructive pulmonary disease (COPD) [25], delayed smoking cessation [26], and possibly a differential response…”
BackgroundPost‐GWAS in Psychiatric Genetics: A Developmental Perspective on the “Other” Next Steps
Dick, D. M., Barr, P. B., Cho, S. B., Cooke, M. E., Kuo, S. I., Lewis, T. J., Neale, Z. E., Salvatore, J. E., Savage, J. E., & Su, J. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12447 · Cited by 46
Lindström, S., Yen, Y., Spiegelman, D. L., & Kraft, P. L. (2009) · Human Heredity · doi:10.1159/000224637 · Cited by 49
Molecular profile of lung cancer in never smokers
Subramanian, J., & Govindan, R. (2013) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2013.07.004 · Cited by 46
“[20] Thorgeirsson TE, Geller F, Sulem P, et al.”
BackgroundIon Channel Mutations in Neuronal Diseases: A Genetics Perspective
Steinlein, O. K. (2012) · Chemical Reviews · doi:10.1021/cr300044d · Cited by 45
Breitling, L. P., Dahmen, N., Mittelstraß, K., Illig, T., Rujescu, D., Raum, E., Winterer, G., & Brenner, H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.004 · Cited by 46
Habenular Signaling in Nicotine Reinforcement
Fowler, C. D., & Kenny, P. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.197 · Cited by 48
Grucza, R. A., Johnson, E. O., Krueger, R. F., Breslau, N., Saccone, N. L., Chen, L., Derringer, J. L., Agrawal, A., Lynskey, M. T., & Bierut, L. J. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00220.x · Cited by 43
“…gene CHRNA5 (rs16969968 and highly correlated proxy SNPs) and nicotine dependence (Amos et al. 2008; Berrettini et al. 2008; Bierut et al. 2008; Grucza et al. 2008a; Thorgeirsson et al. 2008; Weiss et al. 2008; Caporaso et al. 2009; Chen et al. 2009a; Saccone et al. 2009; Wang et al. 2009).”
Rethinking the association between smoking and schizophrenia
Gage, S. H., & Munafo, M. R. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00057-1 · Cited by 44
Biomarkers in cancer epidemiology: an integrative approach
Boffetta, P. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp269 · Cited by 45
Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans
Hansen, H. M., Xiao, Y., Rice, T., Bracci, P. M., Wrensch, M. R., Sison, J. D., Chang, J. S., Smirnov, I. V., Patoka, J., Seldin, M. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq268 · Cited by 40
Mei, D., Zhao, L., Chen, B., Zhang, X., Wang, X., Yu, Z., Ni, X., & Zhang, Q. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1436097 · Cited by 45
“Previous studies positively suggested that the nicotinic acetylcholine receptors (nAChRs) play a significant role in NSCLC predisposition and natural history (Hung et al., 2008; Thorgeirsson et al., 2008).”
BackgroundStrong Association between Two Polymorphisms on 15q25.1 and Lung Cancer Risk: A Meta-Analysis
Gu, M., Dong, X., Zhang, X., Wang, X., Qi, Y., Yu, J. M., & Niu, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037970 · Cited by 44
“For example, the rs1051730 polymorphism is in complete linkage disequilibrium with the potentially pathogenic allele of rs16969968 (D398N) in the CHRNA5 gene [17,29].”
A glimpse into the future – Personalized medicine for smoking cessation
Bierut, L. J., Johnson, E. O., & Saccone, N. L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.009 · Cited by 43
Jaworowska, E., Trubicka, J., Lener, M. R., Masojć, B., Złowocka-Perłowska, E., McKay, J., Renard, H., Oszutowska–Mazurek, D., Wokołorczyk, D., Lubiński, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025057 · Cited by 47
“In support of these findings other studies have shown that this locus is implicated in the risk of chronic obstructive pulmonary disease (COPD) and peripheral arterial disease, both of which have been associated with smoking [5,28].”
ResultPharmacogenetics of smoking cessation therapy
Kortmann, G. L., Dobler, C. J., Bizarro, L., & Bau, C. H. D. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30978 · Cited by 45
“…within the CHRNA5/CHRNA3/CHRNB4 nicotine receptor gene cluster at chromosome 15 have been associated with nicotine dependence [Saccone et al., 2007; Thorgeirsson et al., 2008; Caporaso et al., 2009], numbers of cigarettes per day [Berrettini et al., 2008; Thorgeirsson et al., 2008; Caporaso et…”
BackgroundDistinct Loci in the CHRNA5/CHRNA3/CHRNB4 Gene Cluster Are Associated With Onset of Regular Smoking
Stephens, S. H., Hartz, S. M., Hoft, N. R., Saccone, N. L., Corley, R., Hewitt, J. K., Hopfer, C. J., Breslau, N., Coon, H. H., Chen, X., et al. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21760 · Cited by 41
“Neuronal nicotinic acetylcholine receptor (nAChR) subunit genes are among the top candidates for several smoking-related phenotypes because a cluster of nicotinic receptor genes (CHRNA5/CHRNA3/CHRNB4) on chromosome 15q25 has been repeatedly associated with nicotine dependence, smoking behaviors, and lung cancer [Amos…”
BackgroundGenome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15
Liu, Y.-Z., Pei, Y.-F., Guo, Y.-F., Wang, L., Liu, X.-G., Yan, H., Xiong, D. H., Zhang, Y.-P., Levy, S., Li, J. M., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.3 · Cited by 41
“Genetic association studies have also implicated several genes associated with smoking behavior, such as GABAB2 (6), DOPA decarboxylase (7), and nicotinic acetylcholine receptor α4 subunit (CHRNA4) (8) and α5/α3/β4 cluster on chromosome 15 (9).”
Drgon, T., Johnson, C., Nino, M., Drgonová, J., Walther, D. M., & Uhl, G. R. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31143 · Cited by 41
“Combined data from linkage and initial GWA studies [Uhl et al., 2001, 2008b,c; Liu et al., 2005, 2006; Johnson et al., 2006, 2008; Bierut et al., 2007; Thorgeirsson et al., 2008; Treutlein et al., 2009] suggest that much of the genetic influence on vulnerability to substance dependence is likely to be polygenic.”
BackgroundAssociation of CHRN genes with “dizziness” to tobacco
Ehringer, M. A., McQueen, M. B., Hoft, N. R., Saccone, N. L., Stitzel, J. A., Wang, J. C. C., & Bierut, L. J. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31027 · Cited by 48
“, 2008], cigarettes per day [Berrettini et al., 2008; Thorgeirsson et al., 2008], nicotine dependence [Bierut et al.”
BackgroundPromoter Polymorphisms and Transcript Levels of Nicotinic Receptor CHRNA5
Falvella, F. S., Galvan, A., Colombo, F., Frullanti, E., Pastorino, U., & Dragani, T. A. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq264 · Cited by 43
Genome-wide Association Studies of Cancer Predisposition
Stadler, Z. K., Vijai, J., Thom, P., Kirchhoff, T., Hansen, N. A. L., Kauff, N. D., Robson, M. E., & Offit, K. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.06.009 · Cited by 45
Piasecki, T. M., Piper, M. E., & Baker, T. B. (2010) · Journal of Abnormal Psychology · doi:10.1037/a0020235 · Cited by 41
Alama, A., Bruzzo, C., Cavalieri, Z., Forlani, A., Utkin, Y. N., Casciano, I., & Romani, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020695 · Cited by 40
“The molecular basis of lung cancer have been extensively studied and the interaction between nicotine and nAChRs has been recognized as one of the key events leading to the development of this tumor [2,4,5,6,7,8,9,10,11,16,26].”
BackgroundGenetic Polymorphisms in the Polycomb Group Gene EZH2 and the Risk of Lung Cancer
Yoon, K., Gil, H.-J., Han, J., Park, J., & Lee, J. S. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c422d9 · Cited by 43
Admixture mapping of lung cancer in 1812 African-Americans
Schwartz, A. G., Wenzlaff, A. S., Bock, C. H., Ruterbusch, J. J., Chen, W., Coté, M. L., Artis, A. S., Dyke, A. L. V., Land, S. J., Harris, C. C., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq252 · Cited by 41
Nicotinic acetylcholine receptors and predisposition to lung cancer
Tournier, J., & Birembaut, P. L. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283412ea1 · Cited by 42
Precision oncology of lung cancer: genetic and genomic differences in Chinese population
Shen, H., Zhu, M., & Wang, C. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0086-1 · Cited by 43
Smoking and body weight: Evidence using genetic instruments
Wehby, G. L., Murray, J. C., Wilcox, A. J., & Lie, R. T. (2011) · Economics & Human Biology · doi:10.1016/j.ehb.2011.09.002 · Cited by 44
Borczuk, A., Toonkel, R. L., & Powell, C. A. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200807-076lc · Cited by 51
Myers, C. J., & Lü, B. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.06.2452 · Cited by 42
Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies
Patel, C. J., Kerr, J., Thomas, D. C., Mukherjee, B., Ritz, B. R., Chatterjee, N., Jankowska, M. M., Madan, J. C., Karagas, M. R., McAllister, K. A., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0459 · Cited by 42
“One example of the successful identification of a novel gene-environment interaction through high dimensional analyses is presented by the finding that relatively common variants of CHRNA5 influence smoking behavior (128, 129) and lung cancer risk (130, 131).”
Huang, Y., Liang, L., Moffatt, M. F., Cookson, W., & Lin, X. (2015) · Genetic Epidemiology · doi:10.1002/gepi.21905 · Cited by 47
“…genome-wide association studies (GWAS) have been a common practice for investigating the associations of single nucleotide polymorphisms (SNPs) with complex diseases [Amos et al., 2008; Ferreira et al., 2008; Hung et al., 2008; Moffatt et al., 2007; Thorgeirsson et al., 2008; Wallace et al., 2008].”
BackgroundThe State of Genome-Wide Association Studies in Pulmonary Disease: A New Perspective
Todd, J. L., Goldstein, D. B., Ge, D., Christie, J. D., & Palmer, S. M. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0971pp · Cited by 41
“As the CHRNA3–5 locus was previously reported to be associated with smoking behavior (36), results were adjusted for smoking exposure, and remained highly significant.”
BackgroundBai, L., Yu, H., Wang, H., Su, H., Zhao, J., & Zhao, Y. (2013) · Medical Oncology · doi:10.1007/s12032-012-0414-6 · Cited by 39
Yang, L., Qiu, F., Lu, X., Huang, D., Ma, G., Guo, Y. L., Hu, M., Zhou, Y., Pan, M., Tan, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046071 · Cited by 40
“However, this shared genetic etiology may simply be due to nicotine- dependence because these SNPs are also associated with smoking behavior [21,22].”
BackgroundA Rigorous and Comprehensive Validation: Common Genetic Variations and Lung Cancer
Yang, P., Li, Y., Jiang, R., Cunningham, J. M., Zhang, F., & de Andrade, M. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0710 · Cited by 41
“Five candidate SNPs were selected from eight recent GWAS: (1-8) rs402710 (G->A), rs2736100 (C->A), rs4324798 (G->A), rs16969968 (G->A), and rs8034191 (T->C).”
BackgroundMethodPérez–Morales, R., González‐Zamora, A., González‐Delgado, M. F., Calleros-Rincón, E. Y., Calderón, E. H. O., Martínez‐Ramírez, O. C., & Rubio, J. (2018) · Annals of Human Genetics · doi:10.1111/ahg.12264 · Cited by 41
“Thorgeirsson et al. (2008) and Hung et al. (2008) characterized a genomic region (15q) that has been associated with LC.”
BackgroundGenetic overlap and causal associations between smoking behaviours and mental health
Barkhuizen, W., Dudbridge, F., & Ronald, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93962-7 · Cited by 43
Liu, W., Ao, L., Zhou, Z., Cui, Z.-H., Zhou, Y., Yuan, X., Xiang, Y., Cao, J., & Liu, J.-Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.061 · Cited by 40
Functional studies of lung cancer GWAS beyond association
Long, E., Patel, H., Byun, J., Amos, C. I., & Choi, J. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac140 · Cited by 42
Addiction as a Systems Failure: Focus on Adolescence and Smoking
Baler, R., & Volkow, N. D. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.12.008 · Cited by 48
Chromosome 15q25 (CHRNA3-CHRNA5) Variation Impacts Indirectly on Lung Cancer Risk
Wang, Y., Broderick, P., Matakidou, A., Eisen, T., & Houlston, R. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019085 · Cited by 39
“Concurrently with publication of these two studies Thorgeirsson et al [3] reported a statistically significant association with the same 15q25 variants and metrics of nicotine dependence, concluding that this explained the elevated risk of lung cancer they also observed.”
BackgroundWang, J., & Shete, S. S. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20568 · Cited by 41
Wehby, G. L., Jugessur, A., Murray, J. C., Moreno, L. M., Wilcox, A., & Lie, R. T. (2011) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-011-0071-9 · Cited by 38
“Some of the implicated genes are dopamine 2 receptor (DRD2) (Comings et al. 1996; Noble et al. 1994; Spitz et al. 1998), dopamine beta hydroxylase (DBH) (McKinney et al. 2000), DOPA decarboxylase (DDC) (Ma et al. 2005; Yu et al. 2006), Cholecystokinin (CCK) (Comings et al. 2001), Tryptophan Hydroxylase (TPH) (Lerman e…”
BackgroundInfluentialZhou, H., Yang, J., Li, D., Xiao, J., Wang, B., Wang, L., Ma, C., Xu, S., Ou, X., & Feng, Y. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.104 · Cited by 40
Beyond Cigarettes Per Day. A Genome-Wide Association Study of the Biomarker Carbon Monoxide
Bloom, A. J., Hartz, S. M., Baker, T. B., Chen, L.-S., Piper, M. E., Fox, L. W., Martínez, M., Hatsukami, D. K., Johnson, E. O., Laurie, C. C., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201401-010oc · Cited by 40
Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies
Musolf, A. M., Simpson, C. L., de Andrade, M., Mandal, D. M., Gaba, C., Yang, P., Li, Y., You, M., Kupert, E. Y., Anderson, M. W., et al. (2017) · Genes · doi:10.3390/genes8010036 · Cited by 47
“[43] suggested the region affected smoking behavior, Amos et al.”
BackgroundBhalala, O. G., Nath, A. P., UK Brain Expression Consortium, Inouye, M., & Sibley, C. R. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007607 · Cited by 38
Balancing neurotrophin pathway and sortilin function: Its role in human disease
Al-Yozbaki, M., Acha‐Sagredo, A., George, A., Liloglou, T., & Wilson, C. M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188429 · Cited by 41
Yang, P. (2011) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0031-1272865 · Cited by 41
Schroedl, C. J., & Kalhan, R. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834f2080 · Cited by 41
Stroud, L. R., Papandonatos, G. D., Shenassa, E., Rodriguez, D., Niaura, R., LeWinn, K. Z., Lipsitt, L. P., & Buka, S. L. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.024 · Cited by 36
Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease
Kedmi, M., Bar‐Shira, A., Gurevich, T., Giladi, N., & Orr‐Urtreger, A. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-66 · Cited by 44
“Genetic analysis of isolated populations derived from relatively few founders offers a powerful route for the identification of genetic risk factors [11].”
BackgroundGlobal burden of cancers attributable to tobacco smoking, 1990–2019: an ecological study
Sharma, R., & Rakshit, B. (2022) · The EPMA Journal · doi:10.1007/s13167-022-00308-y · Cited by 38
Cumulative effect of genome‐wide association study‐identified genetic variants for bladder cancer
Wang, M., Chu, H., Lv, Q., Wang, L., Yuan, L., Fu, G., Tong, N., Qin, C., Yin, C., Zhang, Z., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28898 · Cited by 37
The P300 event-related potential and smoking — A population-based case–control study
Mobascher, A., Brinkmeyer, J., Warbrick, T., Wels, C., Wagner, M., Gründer, G., Spreckelmeyer, K. N., Wienker, T. F., Diaz-Lacava, A. N., Dahmen, N., et al. (2010) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2010.06.002 · Cited by 39
Ito, H. M., McKay, J., Hosono, S., Hida, T., Yatabe, Y., Mitsudomi, T., Brennan, P., Tanaka, H., & Matsuo, K. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182475028 · Cited by 37
Yang, J., & Li, M. D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.67 · Cited by 38
Pharmacogenomics of Platinum-Based Chemotherapy Sensitivity in NSCLC: Toward Precision Medicine
Yin, J., Li, X., Zhou, H., & Liu, Z. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0074 · Cited by 38
RGS17: An Emerging Therapeutic Target for Lung and Prostate Cancers
Bodle, C., Mackie, D. I., & Roman, D. L. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.91 · Cited by 40
Investigation on Cardiovascular Risk Prediction Using Genetic Information
Pu, L., Zhao, Z., & Zhang, Y. (2012) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/titb.2012.2205009 · Cited by 38
“…59 SNPs for LDL cholesterol [50]–[52], [53], [55], [56], [59], [60]–[64]; 60 SNPs for BMI [15], [65]–[72], one SNP for nicotine dependence [73]; 90 SNPs for Type 2 Diabetes [74]–[96]; 37 SNPs for C-reactive protein levels [97]–[102], etc.) Although so many SNPs have been discovered to be…”
BackgroundDevelopment of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions
Harmey, D., Griffin, P. R., & Kenny, P. J. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts201 · Cited by 37
“, 2008; Wang, Broderick, Matakidou, Eisen, & Houlston, 2010), likely reflecting higher levels of tobacco dependence in individuals carrying risk alleles and consequently greater exposure to carcinogens contained in tobacco smoke (Le Marchand et al., 2008; Thorgeirsson et al., 2008).”
BackgroundGenetic Factors Control Nicotine Self-Administration in Isogenic Adolescent Rat Strains
Chen, H., Hiler, K. A., Tolley, E. A., Matta, S. G., & Sharp, B. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044234 · Cited by 37
“7% of the variance to smoke [10–12].”
BackgroundBordas, A., Cedillo, J. L., Arnalich, F., Esteban‐Rodríguez, I., Guerra, L., de Castro, J., Martín-Sánchez, C., Atienza, G., Fernández‐Capitán, C., Blanco, J. J. R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18948 · Cited by 40
Tobacco use disorder and treatment: new challenges and opportunities
Ziedonis, D. M., Das, S., & Larkin, C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/dziedonis · Cited by 43
Wang, G., Bai, Y., Fu, W., Feng, Y., Chen, W., Li, G., Wu, X., Meng, H., Liu, Y., Wei, W., et al. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108747 · Cited by 36
MicrobiomeGWAS: A Tool for Identifying Host Genetic Variants Associated with Microbiome Composition
Hua, X., Song, L., Yu, G., Vogtmann, E., Goedert, J. J., Abnet, C. C., Landi, M. T., & Shi, J. (2022) · Genes · doi:10.3390/genes13071224 · Cited by 39
Gallego, X., Ruiz‐Medina, J., Valverde, O., Molas, S., Robles, N., Sabrià, J., Crabbe, J. C., & Dierssen, M. (2012) · Alcohol · doi:10.1016/j.alcohol.2011.11.005 · Cited by 41
“…dependence (Agrawal et al., 2008; Baker et al., 2009; Berrettini et al., 2008; Chen et al., 2009; Grucza et al., 2010; Saccone et al., 2009; Spitz, Amos, Dong, Lin, & Wu, 2008; Stevens et al., 2008; Thorgeirsson et al., 2008; and see Bierut, 2010; Schlaepfer, Hoft, & Ehringer, 2008 for review).”
Acetylcholine receptor pathway in lung cancer: New twists to an old story
Niu, X., & Lu, S. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i4.667 · Cited by 39
Wu, H., Qiao, N., Wang, Y., Jiang, M., Wang, S., Wang, C., & Hu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076372 · Cited by 39
Bloom, A. J., Baker, T. B., Chen, L.-S., Breslau, N., Hatsukami, D. K., Bierut, L. J., & Goate, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt432 · Cited by 40
In search of causal variants: refining disease association signals using cross-population contrasts
Saccone, N. L., Saccone, S. F., Goate, A., Grucza, R. A., Hinrichs, A. L., Rice, J. P., & Bierut, L. J. (2008) · BMC Genetics · doi:10.1186/1471-2156-9-58 · Cited by 38
“This SNP or its r2 proxies have now also demonstrated association with lung cancer [13-15].”
BackgroundResultInfluentialLung Cancer Screening: Review and Performance Comparison Under Different Risk Scenarios
Tota, J. E., Ramanakumar, A. V., & Franco, E. L. (2013) · Lung · doi:10.1007/s00408-013-9517-x · Cited by 37
“ary function [70], serum biomarkers [71–73], and genetic polymorphism data [18, 74–79] also is expected to improve the predictive performance of these models.”
BackgroundGenetic Variation in the Dopamine Pathway and Smoking Cessation
David, S. P., & Munafo, M. R. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.9.1307 · Cited by 38
The role of iron in pulmonary pathology
Khiroya, H., & Turner, A. M. (2015) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-015-0031-2 · Cited by 37
“As well as being identified in relation to lung cancer, these genes are also relevant to nicotine addiction [41–43].”
BackgroundLung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer
Hjelmborg, J., Korhonen, T., Holst, K. K., Skytthe, A., Pukkala, E., Kutschke, J., Harris, J. R., Mucci, L. A., Christensen, K., Czene, K., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207921 · Cited by 39
Identification of shared genetic variants between schizophrenia and lung cancer
Zuber, V., Jönsson, E. G., Frei, O., Witoelar, A., Thompson, W. K., Schork, A. J., Bettella, F., Wang, Y., Djurovic, S., Smeland, O. B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-16481-4 · Cited by 38
“This has a concordant association between lung cancer and smoking, as reported earlier 14,18 , and the effect direction is also concordant for SCZ.”
BackgroundDeYoung, C. G., & Blain, S. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108264822.026 · Cited by 38
Metadata
- Authors
- Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., Stacey, S. N., Bergthorsson, J. T., Thorlacius, S., Gudmundsson, J., Jonsson, T., Jakobsdottir, M., Saemundsdottir, J., Olafsdottir, O., Gudmundsson, L. J., Bjornsdottir, G., Kristjansson, K., Skuladottir, H., Isaksson, H. J., Gudbjartsson, T., Jones, G. T., Mueller, T., Gottsäter, A., Flex, A., Aben, K. K. H., de Vegt, F., Mulders, P. F. A., Isla, D., Vidal, M. J., Asin, L., Saez, B., Murillo, L., Blondal, T., Kolbeinsson, H., Stefansson, J. G., Hansdottir, I., Runarsdottir, V., Pola, R., Lindblad, B., van Rij, A. M., Dieplinger, B., Haltmayer, M., Mayordomo, J. I., Kiemeney, L. A., Matthiasson, S. E., Oskarsson, H., Tyrfingsson, T., Gudbjartsson, D. F., Gulcher, J. R., Jonsson, S., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- University of Otago (NZ)
- Convent Hospital of the Brothers of Saint John of God (AT)
- Skåne University Hospital (SE)
- Università Cattolica del Sacro Cuore (IT)
- Radboud University Medical Center (NL)
- Hospital Universitario Reina Sofía (ES)
- National University Hospital of Iceland (IS)
- Instituto de Nanociencia y Materiales de Aragón (ES)
- Corresponding author
- Thorgeirsson, Thorgeir E.
- ORCID
- Venue
- Nature
- Published
- 2008-04
- Volume
- 452
- Issue
- 7187
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4539558
- OpenAlex
- W2118082971
- Cited by
- 1,523
- References
- 45
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 29 · 2023: 41 · 2022: 33 · 2021: 36 · 2020: 94 · 2019: 48 · 2018: 56 · 2017: 79 · 2016: 80 · 2015: 107 · 2014: 91 · 2013: 100 · 2012: 145
- FWCI
- 120.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- European Commission
- National Institute on Drug Abuse (R01DA017932)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- nicotinic acetylcholine receptors, nicotine dependence, smoking quantity, lung cancer susceptibility, peripheral arterial disease, gene-environment interaction, genetic susceptibility, smoking-related diseases
- MeSH terms
- Chromosomes, Human, Pair 15, Europe, Female, Multigene Family, Genotype, Humans, Lung Neoplasms, Male, New Zealand, Receptors, Nicotinic, Smoking, Tobacco Use Disorder, Odds Ratio, Peripheral Vascular Diseases, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.